
(a closed-ended investment company incorporated in
(the "Company")
Attached is a link to the Monthly Investment Report for
http://www.rns-pdf.londonstockexchange.com/rns/6090C_1-2025-10-8.pdf
September had a
The board have continued their buybacks. Over the third quarter, they have purchased over 5.4 million shares. This brings the year to date total to over 36 million shares, or
Unsurprisingly given the robust backdrop in stock markets, our derivative protections were the main drag on performance. We bolstered them over the month, including the return of VIX call options, which profit from jumps in market volatility. They sit alongside our extensive stock market downside protections and defences against higher borrowing costs in credit markets which are - to our eyes - deeply complacently valued. So our cautious positioning reflects elevated market valuations, sentiment and positioning facing a plethora of potential near-term potholes, including delayed tariff fallout, uncertainty over the path of economic growth, inflation and rates plus cracks in the credit market. And, as firms compete to announce the biggest AI capex numbers for very uncertain returns, one doesn't need to be a Delphic oracle to see that there's some froth around.
Enquiries:
Apex Fund and
Company Secretary
DDI: +44(0)20 3530 3653
Email: ruffercosec@apexgroup.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the